about
Mutated in colorectal cancer, a putative tumor suppressor for serrated colorectal cancer, selectively represses beta-catenin-dependent transcriptionTumor Budding: The Name is EMT. Partial EMTThe biological complexity of colorectal cancer: insights into biomarkers for early detection and personalized careTumor Budding, Micropapillary Pattern, and Polyploidy Giant Cancer Cells in Colorectal Cancer: Current Status and Future ProspectsMolecular and pathogenetic aspects of tumor budding in colorectal cancerEndometrial glandular dysplasia: a putative precursor lesion of uterine papillary serous carcinoma. Part II: molecular features.Clinicopathologic impacts of poorly differentiated cluster-based grading system in colorectal carcinomaTWIST1 and TWIST2 promoter methylation and protein expression in tumor stroma influence the epithelial-mesenchymal transition-like tumor budding phenotype in colorectal cancerMicrosatellite analysis of the adenomatous polyposis coli (APC) gene and immunoexpression of beta catenin in nephroblastoma: a study including 83 cases treated with preoperative chemotherapyTumor Budding in Colorectal Carcinoma: Confirmation of Prognostic Significance and Histologic Cutoff in a Population-based Cohort.Analysis of molecular aberrations of Wnt pathway gladiators in colorectal cancer in the Kashmiri population.The importance of accurate pathological assessment of lymph node involvement in colorectal cancer.Tumour budding at the deepest invasive margin correlates with lymph node metastasis in submucosal colorectal cancer detected by anticytokeratin antibody CAM5.2.Classification of colorectal cancer based on correlation of clinical, morphological and molecular features.Tumour budding in colorectal carcinoma.A multigene mutation classification of 468 colorectal cancers reveals a prognostic role for APC.Crosstalk between tumor cells and microenvironment via Wnt pathway in colorectal cancer dissemination.miR-582-5P induces colorectal cancer cell proliferation by targeting adenomatous polyposis coli.Mucins and Wnt/β-catenin signaling in gastrointestinal cancers: an unholy nexus.Intratumoural budding (ITB) in preoperative biopsies predicts the presence of lymph node and distant metastases in colon and rectal cancer patients.Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: tumor budding as oncotarget.Prognostic significance of tumor budding in gastrointestinal tumors.Tumour budding: a promising parameter in colorectal cancer.Lynch syndrome-associated neoplasms: a discussion on histopathology and immunohistochemistry.Novel biomarkers for the prediction of metastasis in colorectal cancer.Tumor budding in upper gastrointestinal carcinomas.Tumor Budding, uPA, and PAI-1 in Colorectal Cancer: Update of a Prospective Study.Diagnostic reproducibility of tumour budding in colorectal cancer: a multicentre, multinational study using virtual microscopy.Invasive behavior of ulcerative colitis-associated carcinoma is related to reduced expression of CD44 extracellular domain: comparison with sporadic colon carcinoma.Progressive loss of E-cadherin immunoexpression during cervical carcinogenesis.Wnt pathway may not be implicated in all routes to colorectal cancer.The apoptotic and proliferation rate of tumour budding cells in colorectal cancer outlines a heterogeneous population of cells with various impacts on clinical outcome.MicroRNA-21 promotes tumour malignancy via increased nuclear translocation of β-catenin and predicts poor outcome in APC-mutated but not in APC-wild-type colorectal cancer.Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016.Tumour budding at invasive margins and outcome in colorectal cancer.Expression of Wnt-signaling pathway genes and their associations with miRNAs in colorectal cancer.Colorectal carcinomas with submucosal invasion (pT1): analysis of histopathological and molecular factors predicting lymph node metastasis.DNA profiling of tumor buds in colorectal cancer indicates that they have the same mutation profile as the tumor from which they derive.Tyrosine kinase receptor B (TrkB) expression in colorectal cancers highlights anoikis resistance as a survival mechanism of tumour budding cells.Detection of APC gene deletions in colorectal malignancies using quantitative PCR in a Chinese population.
P2860
Q24308753-581E1505-006A-4CD6-9545-798158C27829Q26748136-9BCD2B97-7675-43DF-ABEF-5F5D9EA4EC5AQ28066460-E68EA7C1-827A-41CC-87E7-B67031745F78Q28075498-7D6D6C29-526F-4E88-8A6D-E6D57A07E142Q28085313-0D962691-3F2F-4210-99F2-76B617E2F427Q31122061-7B53891A-771B-40D3-B6C6-AD1EA0CD8617Q34779452-D270946F-87D2-4B71-A6A7-34F8293F65D6Q35176169-F0B6B33A-A633-4A88-B938-0656D1113FDAQ35588287-6E0D39C1-3148-4E87-99ED-0D92DA60A9D3Q36054317-2059B6A5-8274-4C14-9E4B-4BB32A29711DQ36477008-4EE431B0-F9A9-4A16-AEB4-7269CE0FF850Q36511364-4918169F-2085-4215-9623-F53190F6D70CQ36613606-66831513-C736-4065-942F-22C2D2848F0AQ36699559-28525E89-BC3B-4875-A31E-09D4A702A6C6Q36699565-C8BBA0FF-CE05-42B7-A061-0753C8BAE941Q37017721-DC6A26AE-3F89-43A4-A8F3-40847AE25218Q37113566-A1137FFE-DAE9-41D9-A4C3-E88C2B6892FCQ37233140-63C9803D-19A8-4A3F-8DB2-B10145B10662Q37238133-26D94414-8093-45E6-B7FA-B587994FCC98Q37594364-1C59E1C2-E5BE-4678-AA9A-1B42C35554A1Q37840946-AC775AB1-62A9-4EB6-A50E-742C39A4AD30Q37945638-08AEDB0C-ABAA-4FEC-9DAB-DF57552573D8Q38005295-E68F5E50-5579-4C0C-A640-46DF71430C93Q38084166-C1C556A2-D7D5-40DE-8CB2-ADC8CF5A59A7Q38093253-1076D03C-79F9-42CB-B128-0A775CE7AE71Q38245240-35C97EF0-11F2-4553-A7B7-12A494945378Q38912093-B56ECD6C-06C1-41C6-A490-F2F64AFB8778Q40046627-24592E0C-67C2-4102-9BF5-86CA2B0FA18EQ41789555-AB537F63-CFE6-462F-BE88-90225C42A63AQ42467226-88EC8984-F583-4B46-A599-495AC124C5FEQ42843324-9DEF9A56-BFD1-47EF-B840-426528791D57Q43587615-B4ED616E-70DC-48F1-88D7-235B6D743F97Q44577216-04470750-44A6-465B-B95C-D04075C2554CQ46067914-BFABA773-AB1B-438F-9FF1-378CC791ECC9Q46851656-09EF7DF3-2DFB-459D-B6D0-8F3A56A4C5D4Q49787639-414E9E33-9FAD-43AB-B2DF-F82DAAB45441Q54171582-949B04A4-969C-41C7-9C9E-8ECD36F695BBQ54286640-4E216BB3-1F70-4647-AC5F-F89458CBBCD0Q54310690-8B55300F-37AE-4B72-9B7B-9C5FF677CDD4Q54367297-5D78163F-C49D-45CD-A674-C1A5386ABCC5
P2860
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
APC mutation and tumour budding in colorectal cancer.
@ast
APC mutation and tumour budding in colorectal cancer.
@en
type
label
APC mutation and tumour budding in colorectal cancer.
@ast
APC mutation and tumour budding in colorectal cancer.
@en
prefLabel
APC mutation and tumour budding in colorectal cancer.
@ast
APC mutation and tumour budding in colorectal cancer.
@en
P2093
P2860
P356
P1476
APC mutation and tumour budding in colorectal cancer.
@en
P2093
B A Leggett
B Gabrielli
V L J Whitehall
P2860
P356
10.1136/JCP.56.1.69
P407
P577
2003-01-01T00:00:00Z